Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 14, Issue 5, Pages 1098-1102
Publisher
Informa UK Limited
Online
2017-10-03
DOI
10.1080/21645515.2017.1378841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data
- (2016) Fati Sidikou et al. LANCET INFECTIOUS DISEASES
- Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
- (2015) Andromachi Karachaliou et al. CLINICAL INFECTIOUS DISEASES
- Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa
- (2015) Monique Berlier et al. CLINICAL INFECTIOUS DISEASES
- Technical Development of a New Meningococcal Conjugate Vaccine
- (2015) Carl E. Frasch et al. CLINICAL INFECTIOUS DISEASES
- Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool
- (2015) Laurence Cibrelus et al. CLINICAL INFECTIOUS DISEASES
- The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine
- (2015) JOURNAL OF INFECTIOUS DISEASES
- Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin
- (2014) Simona Zipursky et al. VACCINE
- Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt
- (2013) Sara Tartof et al. PLoS One
- Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
- (2012) Paul A. Kristiansen, Fabien Diomandé, Absatou Ky Ba, Idrissa Sanou, Abdoul–Salam Ouédraogo, Rasmata Ouédraogo, Lassana Sangaré, Denis Kandolo, Flavien Aké, Inger Marie Saga, Thomas A. Clark, Lara Misegades, Stacey W. Martin, Jennifer Dolan Thomas, Sylvestre R. Tiendrebeogo, Musa Hassan-King, Mamoudou H. Djingarey, Nancy E. Messonnier, Marie-Pierre Préziosi, F. Marc LaForce, Dominique A. Caugant CLINICAL INFECTIOUS DISEASES
- Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
- (2012) Mamoudou H. Djingarey et al. VACCINE
- Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa
- (2011) David M. Bishai et al. HEALTH AFFAIRS
- Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine
- (2011) F. Marc LaForce et al. HEALTH AFFAIRS
- Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
- (2011) Samba O. Sow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa
- (2008) Che-Hung Lee et al. VACCINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started